Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in Am J Clin Pathol

Retrieve available abstracts of 17 articles:
HTML format
Text format



Single Articles


    January 2017
  1. SERDY KM, Leone JP, Dabbs DJ, Bhargava R, et al
    Male Breast Cancer: A Single-Institution Clinicopathologic and Immunohistochemical Study.
    Am J Clin Pathol. 2017 Jan 24. pii: aqw207. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. HOU Y, Nitta H, Li Z
    HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer.
    Am J Clin Pathol. 2017 Jan 21. pii: aqw211. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. SERDY KM, Leone JP, Dabbs DJ, Bhargava R, et al
    Male Breast Cancer.
    Am J Clin Pathol. 2017;147:110-119.
    PubMed     Text format    


    October 2016
  4. SHEN T, Zhang K, Siegal GP, Wei S, et al
    Prognostic Value of E-Cadherin and beta-Catenin in Triple-Negative Breast Cancer.
    Am J Clin Pathol. 2016.
    PubMed     Text format     Abstract available


  5. LI X, Wetherilt CS, Krishnamurti U, Yang J, et al
    Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple-Negative Breast Cancer.
    Am J Clin Pathol. 2016;146:496-502.
    PubMed     Text format     Abstract available


    September 2016
  6. SHAO T, Wood M, Wing A, Hnatovska M, et al
    Comparison of HER2 Dual-Color and Fluorescence In Situ Hybridization in Breast Cancer: A Cohort Study Emphasizing Equivocal Cases.
    Am J Clin Pathol. 2016;146:339-45.
    PubMed     Text format     Abstract available


    June 2016
  7. LI XB, Krishnamurti U, Bhattarai S, Klimov S, et al
    Biomarkers Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Am J Clin Pathol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  8. PRENDEVILLE S, Feeley L, Bennett MW, O'Connell F, et al
    Reflex Repeat HER2 Testing of Grade 3 Breast Carcinoma at Excision Using Immunohistochemistry and In Situ Analysis: Frequency of HER2 Discordance and Utility of Core Needle Biopsy Parameters to Refine Case Selection.
    Am J Clin Pathol. 2016;145:75-80.
    PubMed     Text format     Abstract available


    December 2015
  9. EAST EG, Pang JC, Kidwell KM, Jorns JM, et al
    Utility of estrogen receptor, progesterone receptor, and HER-2/neu analysis of multiple foci in multifocal ipsilateral invasive breast carcinoma.
    Am J Clin Pathol. 2015;144:952-9.
    PubMed     Text format     Abstract available


  10. GINTER PS, Varma S, Liu YF, Shin SJ, et al
    The minimal carcinoma triple stain is superior to commercially available multiplex immunohistochemical stains: breast triple stain and LC/DC breast cocktail.
    Am J Clin Pathol. 2015;144:869-79.
    PubMed     Text format     Abstract available


  11. PAPADIMITRIOU M, Kaptanis S, Polymeropoulos E, Mitsopoulos G, et al
    Nuclear grade plus proliferation grading system for invasive ductal carcinoma of the breast: validation in a tertiary referral hospital cohort.
    Am J Clin Pathol. 2015;144:837-43.
    PubMed     Text format     Abstract available


    November 2015
  12. BLANCO LZ, Thurow TA, Mahajan A, Susnik B, et al
    Multinucleation is an objective feature useful in the diagnosis of pleomorphic lobular carcinoma in situ.
    Am J Clin Pathol. 2015;144:722-6.
    PubMed     Text format     Abstract available


  13. ROY-CHOWDHURI S, de Melo Gagliato D, Routbort MJ, Patel KP, et al
    Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing.
    Am J Clin Pathol. 2015;144:713-21.
    PubMed     Text format     Abstract available


    October 2015
  14. PETRAU C, Clatot F, Cornic M, Berghian A, et al
    Reliability of Prognostic and Predictive Factors Evaluated by Needle Core Biopsies of Large Breast Invasive Tumors.
    Am J Clin Pathol. 2015;144:555-62.
    PubMed     Text format     Abstract available


  15. HICKS DG, Fitzgibbons P, Hammond E
    Core vs Breast Resection Specimen: Does It Make a Difference for HER2 Results?
    Am J Clin Pathol. 2015;144:533-5.
    PubMed     Text format    


    September 2015
  16. WASSERMAN JK, Parra-Herran C
    Regressive change in high-grade ductal carcinoma in situ of the breast: histopathologic spectrum and biologic importance.
    Am J Clin Pathol. 2015;144:503-10.
    PubMed     Text format     Abstract available


  17. WELLS JM, Ginter PS, Liu Y, Chen Z, et al
    Evaluating the utility of trefoil factor 1 as a mammary-specific immunostain compared and in conjunction with GATA-3 and mammaglobin in the distinction between carcinoma of breast and lung.
    Am J Clin Pathol. 2015;144:444-51.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: